Hematology / Oncology CE Activities

The Road to Cures Series: CAR-T Therapy: What’s in the CARds? – Module 1 of 5

0.50 CE Credit(s)

EXPIRES: April 5, 2023

Perspectives on Optimizing Immunotherapy in Advanced BCC and CSCC

0.50 CE Credit(s)

EXPIRES: April 5, 2023

Challenging Cases: HPI Switching in BCC, Adjuvant Therapy in CSCC

0.25 CE Credit(s)

EXPIRES: April 5, 2023

Challenging Cases: BCC in HIV Infection, New Skin Lesions in Metastatic CSCC

0.25 CE Credit(s)

Hematology / oncology blog

Targeting BCMA: A New Path in Relapsed/Refractory Multiple Myeloma

In triple- and quad-refractory myeloma, median survival was only about 9 months, and less than 6 months in penta-refractory disease.

Hematology / Oncology
Blog

Navigating Immunotherapy in Advanced NSCLC: What Every Oncologist Should Know

The advent of immunotherapy has significantly extended survival and revolutionized care in advanced non-small cell lung cancer (NSCLC).

Hematology / Oncology
Blog

Is Immunotherapy Right for Your Patient with Nonmelanoma Skin Cancer?

The primary goal of treatment in nonmelanoma skin cancer (NMSC) is tumor elimination with maximal preservation of function and cosmesis.

Hematology / Oncology
Blog

RMEI Presentations

Answering the Call to Action: How Nurses Have Become Progressively More Involved in Immunotherapy IME (2018 to Present)

Optimizing treatment in BCC and CSCC: 3 years of oncology CME

Iterative Data-Driven Education for Evolving Strategies of Care in cSCC

When the Patient Voice is Heard in Education, Does the Clinician Listen?

RMEI DECISION SUPPORT AIDS

Intravitreal Anti-VEGF & Bispecific Therapies for DME & nAMD

In late 2022, the ocular implant, insertion tool assembly, (including the drug vial & initial fill needle) for ranibizumab PDS were voluntarily recalled due to septum dislodgement and paused implantations including ongoing global clinical trials; this did not include the refill vial and needle.

Hematology / Oncology
Decision Support Aid

Cervical Cancer: What You Need to Know About Screening, Symptoms, and Treatments

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients. An estimated 13,960 women are diagnosed with invasive cervical cancer every year.

Hematology / Oncology
Decision Support Aid

Seeing Nonmelanoma Skin Cancers Through A New Lens: The Role and Place of Immunotherapy

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Hematology / Oncology
Decision Support Aid

Relapsed or Refractory Chronic-Phase: CHRONIC MYELOID LEUKEMIA (CML)

This Decision Support Aid serves as a quick reference to help clinicians to apply information to their daily practice and care of patients.

Hematology / Oncology
Decision Support Aid

LATEST HEMATOLOGY / ONCOLOGY ARTICLES

Latest Hematology / Oncology Articles

From Where It Stems June 5, 2025
A 62-year-old woman presented with a 1-day history of chest pain on the left side that had radiated to her shoulder and back and was associated with dyspnea, diaphoresis, and lightheadedness.
Ayelet Shapira-Daniels, Karishma Pareek, Matthew Cozzolino, Jean-Antoine Ribeil, Eric Awtry
Debating Race and the Diagnosis of Anemia — How Medicine Moved Away from Race-Based Standards June 5, 2025
As physicians continue to debate the role of race in clinical algorithms, the unusual history of debates over race-specific anemia diagnosis may be instructive.
Wingel Xue, David S. Jones
Biopsy of Peripheral Lung Nodules — Inside Out or Outside In? June 5, 2025
Pulmonary nodules are detected in more than 1.5 million U.S. residents every year. Nodules are identified incidentally on at least 20% of all diagnostic chest computed tomographic (CT) scans and are found even more commonly on screening low-dose CT scans. Most lung nodules are harmless. However, approximately 5% of nodules...
Michael K. Gould

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

RMEI has released pairings of live and online programs approximately twice per year since 2016 grouped into “phases” which share clinical areas of focus and are based on findings from the previous phase of education. In total, 16 activities have launched to date with 4 activities currently live. The purpose of this analysis is to better understand the impact of multi-year iterative education on a clinical audience. Presented at: Society for Academic CME (SACME), virtual, February 2021; Accreditation Council for Continuing Medical Education (ACCME), virtual, April 2021.

Allergy & Immunology
2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Gastroenterology
2021

Hematology / Oncology CE Activities

Hematology / oncology blog

Targeting BCMA: A New Path in Relapsed/Refractory Multiple Myeloma

Navigating Immunotherapy in Advanced NSCLC: What Every Oncologist Should Know

Is Immunotherapy Right for Your Patient with Nonmelanoma Skin Cancer?

RMEI Presentations

Answering the Call to Action: How Nurses Have Become Progressively More Involved in Immunotherapy IME (2018 to Present)

Optimizing treatment in BCC and CSCC: 3 years of oncology CME

Iterative Data-Driven Education for Evolving Strategies of Care in cSCC

When the Patient Voice is Heard in Education, Does the Clinician Listen?

RMEI DECISION SUPPORT AIDS

Intravitreal Anti-VEGF & Bispecific Therapies for DME & nAMD

Cervical Cancer: What You Need to Know About Screening, Symptoms, and Treatments

Seeing Nonmelanoma Skin Cancers Through A New Lens: The Role and Place of Immunotherapy

Relapsed or Refractory Chronic-Phase: CHRONIC MYELOID LEUKEMIA (CML)

LATEST HEMATOLOGY / ONCOLOGY ARTICLES

RMEI LIGHTNING TALKS

4 Years, 16 Live & Online Activities, 6000+ Clinicians: What we've learned so far

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

Previously Published CE Activities